Retrophin's Series A Round

Retrophin raised a round of funding on May 07, 2012. Investors include MSMB Capital.

Retrophin is a biopharmaceutical company focused on discovering, developing and marketing innovative therapies for debilitating and often life-threatening diseases. The company is dedicated to working…

Articles about Retrophin's Series A Round: